635 SIGNIFICANCE OF INTRAHEPATIC TUMOR CONTROL IN THE PROGNOSIS OF PATIENTS WITH HEPATOCELLULAR CARCINOMA AND EXTRAHEPATIC METASTASES

635 SIGNIFICANCE OF INTRAHEPATIC TUMOR CONTROL IN THE PROGNOSIS OF PATIENTS WITH HEPATOCELLULAR CARCINOMA AND EXTRAHEPATIC METASTASES

POSTERS tumour ≥3 cm. Tumour size without other specification when ≥5 cm has a probability of DFS after LT nearly 4 lower and a probability of recurren...

39KB Sizes 0 Downloads 59 Views

POSTERS tumour ≥3 cm. Tumour size without other specification when ≥5 cm has a probability of DFS after LT nearly 4 lower and a probability of recurrence nearly 4 higher. The impact on OS is not as large as for the DFS. These data suggest caution in expanding HCC selection criteria for transplantation based on increasing size of largest nodule, or total tumour size. 634 BALLOON-OCCLUDED PERCUTANEOUS RADIO-FREQUENCY THERMAL ABLATION (RFA) PLUS TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE): A NEW COMBINED SINGLE-STEP THERAPY FOR TREATMENT OF MULTINODULAR UNRESECTABLE HEPATOCELLULAR CARCINOMA R. Iezzi1 , V. Cesario1 , F.R. Ponziani1 , G. Gigante1 , G. Caracciolo1 , E. Rinninella1 , M.A. Zocco1 , A.M. de Gaetano1 , M. Siciliano1 , A. Milani1 , L. Miele1 , G. Gasbarrini1,2 , S. Agnes1 , G. Bombardieri1 , F. Giuliante1 , A. Grieco1 , G. Nuzzo1 , M. Pompili1 , M. Basso1 , G.L. Rapaccini1 , E. di Stasio1 , L. Bonomo1 , A. Gasbarrini1 , HEPATOCAT Group for the Multidisciplinary Management of HCC. 1 Catholic University of Rome, 2 Fondazione Ricerca in Medicina, Roma, Italy E-mail: [email protected] Purpose: To evaluate the feasibility and safety of combined single-step therapy with balloon-occluded RFA followed by TACE in patients with multi-nodular unresectable hepatocellular carcinoma. Materials and methods: 10 consecutive patients with multinodular (2–6 nodules) unilobar unresectable HCC and with a target main lesion larger than 3 cm (range: 3.5–6 cm) were enrolled in our single-center multidisciplinary pilot study. The schedule consisted of: percutaneous RFA (single 3-cm monopolar needle insertion) of the target lesion during occlusion of the hepatic artery supplying the tumor followed by lobar TACE (450 mg carboplatin and lipiodol plus temporary embolization with spongostan). Adverse events as well as intra/periprocedural complications were clinically assessed. Early local efficacy was evaluated on 1-month follow-up multiphasic CT based on RECIST criteria. A separated evaluation of target lesions in terms of enhancement, necrotic diameter, presence and distribution of lipiodol uptake was also performed. Results: No major complications occurred. Overall technical success, defined as complete devascularization during the arterial phase of all nodules, was achivied in 7/10 patients with 3 partial response (persistence of hypervascular small nodules). When considering only target lesions, technical success was obtained in all patients, with a nonenhancing area corresponding in shape to the previously identified HCC (necrotic diameter: 3.5–5 cm) always obtained, and with a circonferential peripheral lipiodol uptake, as safety margin of lesion, of at least 0.5 cm (0.5–1.3 cm). Conclusions: Balloon-occluded-RFA plus TACE seems to be a safe and effective combined therapy for the treatment of advanced unresectable HCC lesions, allowing to obtain a high complete local response rate also in large lesions. 635 SIGNIFICANCE OF INTRAHEPATIC TUMOR CONTROL IN THE PROGNOSIS OF PATIENTS WITH HEPATOCELLULAR CARCINOMA AND EXTRAHEPATIC METASTASES S.M. Jung1 , J.W. Jang1 , C.R. You1 , S.H. Yoo1 , J.H. Kwon1 , K.W. Chung1 , C.S. Kay2 , H.S. Jung3 . 1 Internal Medicine, 2 Radiation Oncology, 3 Radiology, The Catholic University of Korea, Seoul, Republic of Korea E-mail: [email protected] Background and Aims: There has been little information about the long-term outcome and prognostic factors in patients with hepatocellular carcinoma (HCC) and extrahepatic metastases. The purpose of this study was to investigate the clinical factors affecting survival after extrahepatic metastasis and to determine the survival benefit of controlling intrahepatic HCC.

Methods: Between 2004 and 2009, a total of 240 consecutive patients with HCC and extrahepatic metastasis were recruited. Based on tumor extent, performance, and hepatic function, the patients underwent locoregional and/or systemic treatments. After 2 months of anti-cancer therapy, the treatment response of the intrahepatic tumor after extrahepatic metastasis was assessed by modified RECIST. Other prognostic parameters were also analyzed. Results: During the mean follow-up of 276 days, 222 patients died; the median survival time was 146 days. Multivariate analysis revealed that Child–Pugh class A (P = 0.018), smaller hepatic tumor size (P = 0.025), absence of portal venous invasion (P = 0.002), single metastatic organ involvement (P = 0.001), and objective treatment response of the intrahepatic tumor (P < 0.001) were the favorable prognostic factors for survival. Of the 183 evaluable patients, 24 achieved complete or partial response for intrahepatic tumors after treatment. The overall survival for the 24 responders was significantly improved, with a median of 521 days, as compared to 170 days for the remaining 159 patients without objective tumor response. The leading cause of death was progressive intrahepatic tumor. Conclusions: Intrahepatic tumor status and hepatic reserve are among the significant predictors of survival in patients with HCC and extrahepatic metastases. This study indicates that even in patients with metastases from advanced HCC, therapeutic approaches to control intrahepatic tumor are important in improving patient survival. 636 OBSERVATION OF BUBBLES AND DETECTION OF HEPATOCYTES IN THE PORTAL VEIN DURING RADIOFREQUENCY ABLATION C. Kawamoto1 , K.-I. Manaka2 , A. Yamauchi3 , K. Kaneko1 , R. Miyamoto1 , H. Shimizu1 , K. Mizuno1 . 1 Department of Medicine, Division of Cardiology, Hepatology, Geriatrics and Integrated Medicine, Nippon Medical School, Tokyo, 2 Institute of International Education and Research, Dokkyo Medical University, Tochigi, 3 Department of Internal Medicine, Yorii Hospital, Saitama, Japan E-mail: [email protected] Background and Aims: Radiofrequency ablation (RFA) for hepatocellular carcinoma is considered as a less-invasive therapeutic technique associated with favorable local control. Although RFA was initially expected to decrease the incidence of local recurrence, sporadic cases of unexpected recurrence, such as intrahepatic dissemination, have been described following RFA. Some of these recurrences may be caused by increased intratumoral pressure. During RFA, high echoic areas can be observed by ultrasound in the vessels. Such high echoic areas are thought to represent steam (bubbles) generated by increased intrahepatic pressure in rapidly heated tissue. Therefore, we used an angioscope to observe the bubbles generated during RFA, and examined hepatocytes in the portal vein. Subjects and methods: Under general anesthesia, laparotomy was performed on 4 pigs. Bubbles in the portal vein were observed by angioscope using a 16-Fr sheath inserted into the portal vein. The 16-Fr sheath was directly inserted into the portal vein. After inserting a 3.8-mm angioscope into the sheath, a guidewire was used to guide the angioscope to the portal vein, and RFA was performed. A 20-mm LeVeen needle electrode and a cooledtip RF needle electrode were used for RFA. The down-streaming blood in the vessel attached to the irradiated part was collected and separated by using Ficoll-gradient method, and cultured for 15 hours to examine the existence of intact hepatocytes. Results: The outflow of bubbles from the RFA site was observed by angioscope at the same time as high echoic areas were observed on ultrasonography. In the fraction of the blood separated by using Ficoll-gradient method, albumin-positive cell clusters were found and were assumedly intact hepatocyte in their morphology.

Journal of Hepatology 2011 vol. 54 | S209–S361

S257